UVA Health Launches National Clinical Trials to Address Long COVID

March 29, 2025 - 00:13

An estimated 50 million Americans may be living with symptoms of varying severity due to Long COVID, a condition that continues to affect many following their initial recovery from COVID-19. In response to this growing health crisis, UVA Health has initiated two national clinical trials aimed at understanding and alleviating the effects of Long COVID.

These trials are designed to explore potential treatments and interventions for individuals suffering from persistent symptoms such as fatigue, brain fog, and respiratory issues. Researchers at UVA Health are collaborating with experts across the country to gather data and share insights that could lead to more effective management strategies for Long COVID.

The trials will involve a diverse group of participants to ensure comprehensive results that reflect the experiences of various demographics. By focusing on the complexities of Long COVID, UVA Health aims to contribute significantly to the ongoing efforts to combat this condition and improve the quality of life for millions of affected individuals.